Correlation Between Arcus Biosciences and Voyager Therapeutics
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Voyager Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Voyager Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and Voyager Therapeutics, you can compare the effects of market volatilities on Arcus Biosciences and Voyager Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Voyager Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Voyager Therapeutics.
Diversification Opportunities for Arcus Biosciences and Voyager Therapeutics
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Arcus and Voyager is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Voyager Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Voyager Therapeutics and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Voyager Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Voyager Therapeutics has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Voyager Therapeutics go up and down completely randomly.
Pair Corralation between Arcus Biosciences and Voyager Therapeutics
Given the investment horizon of 90 days Arcus Biosciences is expected to generate 0.67 times more return on investment than Voyager Therapeutics. However, Arcus Biosciences is 1.49 times less risky than Voyager Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Voyager Therapeutics is currently generating about 0.02 per unit of risk. If you would invest 1,456 in Arcus Biosciences on September 24, 2024 and sell it today you would earn a total of 94.00 from holding Arcus Biosciences or generate 6.46% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Arcus Biosciences vs. Voyager Therapeutics
Performance |
Timeline |
Arcus Biosciences |
Voyager Therapeutics |
Arcus Biosciences and Voyager Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Arcus Biosciences and Voyager Therapeutics
The main advantage of trading using opposite Arcus Biosciences and Voyager Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Voyager Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Voyager Therapeutics will offset losses from the drop in Voyager Therapeutics' long position.Arcus Biosciences vs. Cullinan Oncology LLC | Arcus Biosciences vs. Annexon | Arcus Biosciences vs. Structure Therapeutics American | Arcus Biosciences vs. Relay Therapeutics |
Voyager Therapeutics vs. Fate Therapeutics | Voyager Therapeutics vs. Sana Biotechnology | Voyager Therapeutics vs. Caribou Biosciences | Voyager Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |